↓ Skip to main content

Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1

Overview of attention for article published in Frontiers in immunology, August 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
13 Mendeley